Contract facts
FederalRADIOPHARMACEUTICAL PYLARIFY FSS BPA is a federal award for 250-Network Contract Office 10 (36C250) held by Progenics Pharmaceuticals Inc. Estimated value —. Related solicitation 36C25025Q0870.
Incumbent footprint
Public recordProgenics Pharmaceuticals Inc — $95.0M obligated across 149 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25026A0002?
36C25026A0002 (Radiopharmaceutical pylarify FSS BPA) is a 250-Network Contract Office 10 (36C250) award with an estimated value of —, currently held by Progenics Pharmaceuticals Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-26-A-0002?
36C250-26-A-0002 is the dashed form of PIID 36C25026A0002 (Radiopharmaceutical pylarify FSS BPA), held by Progenics Pharmaceuticals Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25026A0002?
250-Network Contract Office 10 (36C250) awarded 36C25026A0002 to Progenics Pharmaceuticals Inc.
Who is the incumbent on 36C25026A0002?
Progenics Pharmaceuticals Inc is the incumbent with $95.0M across 149 related awards in SCOUT’s public footprint.
When does Progenics Pharmaceuticals Inc’s 36C25026A0002 come up for recompete?
SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.